119
Participants
Start Date
November 3, 2015
Primary Completion Date
January 26, 2017
Study Completion Date
August 13, 2018
Alectinib
Participants will receive oral alectinib at a dose of 600 mg twice daily, taken with food until disease progression, unacceptable toxicity, withdrawal of consent or death.
Docetaxel
Participants will receive docetaxel at a dose of 75 mg/m\^2 of body surface area intravenously every 3 weeks, until disease progression, unacceptable toxicity, withdrawal of consent or death.
Pemetrexed
Participants will receive pemetrexed at a dose of 500 mg/m\^2 of body surface area intravenously every 3 weeks, until disease progression, unacceptable toxicity, withdrawal of consent or death.
Semmelweis Egyetem X; Pulmonologiai Klinika, Budapest
MBAL Serdika EOOD, Sofia
UZ Antwerpen, Edegem
GHdC Site Notre Dame, Charleroi
UZ Gent, Ghent
Evang. Lungenklinik Berlin Klinik für Pneumologie, Berlin
Centre Francois Baclesse, Caen
Irccs Ospedale San Raffaele;Oncologia Medica, Milan
Irccs Istituto Europeo Di Oncologia (IEO); Oncologia Medica, Milan
Pius-Hospital; Klinik fuer Haematologie und Onkologie, Oldenburg
Hospital Universitario La Paz; Servicio de Oncologia, Madrid
Hospital Universitario de Torrejon, Torrejón de Ardoz
Hospital Clinico Universitario Virgen de la Victoria; Servicio de Oncologia, Málaga
Hopital Larrey; Pneumologie, Toulouse
Hopital Du Haut Leveque; Service Des Maladies Respiratoires, Pessac
Istanbul Uni Capa Medical Faculty; Inst. of Oncology, Istanbul
Fachklinik für Lungenerkrankungen, Immenhausen
Ege University Medical Faculty; Chest Diseases, Izmir
Inonu University Medical Faculty Turgut Ozal Medical Center Medical Oncology Department, Malatya
Hospital Universitari i Politecnic La Fe de Valencia, Valencia
Ospedale Provinciale Santa Maria Delle Croci; Oncologia Medica, Ravenna
Hospital de Cruces; Servicio de Oncologia, Bilbao
A.O. Universitaria Pisana-Ospedale Cisanello; Dipartimento Cardio Toracico-Pneumologia Ii, Pisa
Hopital Robert Schuman; Pneumologie, Vantoux
Chonnam National University Hwasun Hospital, Jeollanam-do
Hopital Bichat Claude Bernard ; Service de Pneumologie, Paris
AORN Ospedali dei Colli Ospedale Monaldi; UOC Pneumologia ad indirizzo Oncologico, Napoli
Istituto Nazionale Tumori Fondazione G. Pascale; U.O.C. Oncologia Medica Toraco Polmonare, Napoli
Asklepios-Fachkliniken Muenchen-Gauting; Onkologie, Gauting
Hopital Sainte Musse; Pneumologie, Toulon
Azienda Ospedaliera di Rilievo Nazionale e di Alta Specialita San Giuseppe Moscati, Avellino
Hopital Foch; Pneumologie, Suresnes
POLICLINICO RODOLICO, U.O. di Oncologia Medica, Catania
Zentralklinik Bad Berka GmbH; Abteilung Onkologie und Hämatologie, Bad Berka
Main Military Clinical Hospital named after N.N. Burdenko, Moscow
University сlinic of headaches, Moscow
City Clinical Oncology Hospital, Moscow
City Clinical Oncology Dispensary, Saint Petersburg
"FSBINational Medical Research Center of Oncology named after N.N.Petrov MHRF", Saint Petersburg
S-Pb clinical scientific practical center of specialized kinds of medical care (oncological), Saint Petersburg
Queen Elizabeth Hospital; Clinical Oncology, Hong Kong
Queen Mary Hospital; Dept. of Clinical Oncology, Hong Kong
Azienda Ospedaliera San Camillo Forlanini; U.O.C. Pneumologia Ad Indirizzo Oncologico 1, Rome
Azienda Ospedaliera Di Perugia Ospedale s. Maria Della Misericordia; Oncologia Medica, Perugia
Oslo Universitetssykehus HF; Radiumhospitalet, Oslo
Medical University of Gdansk, Gdansk
Hospital Geral; Servico de Pneumologia, Coimbra
IPO do Porto; Servico de Oncologia Medica, Porto
CHVNG/E_Unidade 1; Servico de Pneumologia, Vila Nova de Gaia
FNsP F. D. Roosevelta Banska Bystrica, II.Ocna klinika SZU, Banská Bystrica
Vychodoslovensky onkologicky ustav, Košice
Korea University Guro Hospital; Oncology, Seoul
Adana Acıbadem Hospital Oncology Department, Adana
Hacettepe Uni Medical Faculty Hospital; Oncology Dept, Ankara
Hoffmann-La Roche
INDUSTRY